本页面由Tiger Trade Technology Pte. Ltd.提供服务

再鼎医药

24.59
-0.4000-1.60%
盘前:24.30-0.2900-1.18%07:42 EDT
成交量:52.45万
成交额:1,299.28万
市值:27.63亿
市盈率:-14.44
高:25.00
开:24.88
低:24.51
收:24.99
52周最高:30.18
52周最低:15.96
股本:1.12亿
流通股本:9,711.04万
量比:0.61
换手率:0.54%
股息:- -
股息率:- -
每股收益(TTM):-1.7030
每股收益(LYR):-1.6026
净资产收益率:-26.91%
总资产收益率:-14.75%
市净率:4.55
市盈率(LYR):-15.34

数据加载中...

2021/03/01

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/11

重要事件披露

8-K - Current report
2021/01/06

重要事件披露

8-K - Current report
2021/01/04

重要事件披露

8-K - Current report
2020/12/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/18

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/18

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/08/13

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/06/17

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/04/29

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/19

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/16

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals